Bio-Path Holdings, Inc. Sale of Stock, Consideration Received Per Transaction
Bio-Path Holdings, Inc. (BPTH) had Sale of Stock, Consideration Received Per Transaction of $2.00 million as of 2024-04-19, per its 10-Q filed 2026-01-13.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedPerTransaction · last filed 2026-01-13
- 2024-04-19: Sale of Stock, Consideration Received Per Transaction $2.00M.
| Period end | Sale of Stock, Consideration Received Per Transaction |
|---|---|
| 2024-04-19 | $2.00M 10-Q · filed 2026-01-13 |